通过对DHODH抑制剂的碎片识别发现了替代的结合体位
Lindsey G DeRatt1, E Christine Pietsch1, Justin S Cisar1
1Janssen Pharmaceutical Research and Development, 1400 McKean Rd., Spring House, Pennsylvania 19477, United States.
研究人员确定了用于急性髓性白血病治疗的新型二甲酸脱酶 (DHODH) 抑制剂. 这些化合物表现出一种新的结合方式和潜力进入大脑,为癌症治疗提供了新的途径.
科学领域:
- 生物化学 生化学
- 药理学 药理学是指药理学的学科.
- 药用化学 医学化学
背景情况:
- 氨酸脱酶 (DHODH) 是一种线粒体酶,对细胞增殖和存活至关重要.
- DHODH是急性髓性白血病 (AML) 的一个有前途的治疗点.
研究的目的:
- 为了确定强大的DHODH抑制剂.
- 探索新的结合方式,改善药物概况.
- 为了评估治疗应用的脑透潜力.
主要方法:
- 使用了一个脚手架跳跃的方法.
- 通过碎片选启动.
- 采用基于结构的药物设计来优化.
- 评估的P-糖蛋白 (P-gp) 流量比率.
主要成果:
- 确定了强大的DHODH抑制剂.
- 发现了一种意想不到的新型抑制剂的结合模式.
- 化合物显示P-gp流量比较低,这表明它们能很好地透大脑.
结论:
- 已识别的DHODH抑制剂代表了AML治疗的有前途的新类化合物.
- 新的结合模式为药物设计提供了新的机会.
- 低的P-gp流量比表明了中枢神经系统应用的潜力.
更多相关视频
07:08Optimization of Synthetic Proteins: Identification of Interpositional Dependencies Indicating Structurally and/or Functionally Linked Residues
Published on: July 14, 2015
10:33Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Published on: October 26, 2015
相关概念视频
Ligand Binding and Linkage
Conserved Binding Sites
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
Ligand Binding Sites
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
The Equilibrium Binding Constant and Binding Strength
Protein-protein Interfaces
Allosteric Proteins-ATCase
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
